PIEZO1 and malaria: Whereas these observations do not exclude potential adverse effects of systemic Piezo1 activation, they are consistent with the fact that individuals harboring certain gain-of-function Piezo1 variants—such as the E756 deletion mutant, which is present in ~18% of individuals of African descent—are generally healthy and show resistance to malaria as well as enhanced athletic performance [10].